Skip to content
Home / Companies / BBNX BBN
Beta Bionics, Inc. (BBNX) XNAS SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Net insider selling (90d)
Latest BBNX Insider Trades
About Beta Bionics, Inc. (BBNX) Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Headquarters IRVINE, CA
Employees 423
Listed 2025
Exchange XNAS https://www.betabionics.com SEC filings for BBNX on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 13 63,227 $896K Option exercise 8 39,756
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
BBNX Insider Transactions (Form 4) 54 57 Form 4 filings on record, the earliest from Aug 19, 2025, newest first. Filing history page 2 of 2.
Date Insider Transaction Security Shares Price Value Jan 13, 2026 GM Gerard J. Michel Grant or award Common Stock 3,997 $0.00
Recent BBNX Form 8-K Filings 5
Recent BBNX Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Jun 29, 2026 - - - - View on EDGAR Jun 26, 2026 - - -
BBNX Insider Trading - FAQ
What is the latest insider trade for BBNX? Beta Bionics, Inc. (BBNX) had 11 insider filings in the last 90 days, with the most recent on 2026-07-02. The full record for BBNX runs to 57 Form 4 filings, the earliest from 2025-08-19. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying BBNX stock? No insider purchases of BBNX were filed in the last 90 days.
How many insiders are selling BBNX stock? 13 insider sales of BBNX were filed in the last 90 days, totaling $896K.
Where can I see BBNX SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks BBNX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow BBNX insider buys? Create a free InsiderAlpha account and press Watch on this page to add BBNX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track BBNX insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Open-market sale
$83K
MH Mark Hopman - Officer Open-market sale $19K
Jun 24, 2026
Market cap $887.20M
P/E ratio -
Dividend yield -
Average volume 1.15M
52 week high $32.71
52 week low $8.80
Today's high -
Today's low -
Open -
Volume -
Previous close $19.72
Shares outstanding 44.99M Market cap
$887.20M
423 employees
BBNX Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 13 sales totaling $896K.
Most-Active BBNX Insiders - Last 90 Days 10 Jan 13, 2026 SC Sean Carney Grant or award Common Stock 3,997 $0.00 -
Jan 13, 2026 AL Adam Lezack Grant or award Common Stock 3,997 $0.00 -
Jan 6, 2026 MM Mike Mensinger - Officer Open-market sale Common Stock 2,200 $30.10 $66K
Dec 2, 2025 SF Stephen Feider - Officer Open-market sale Common Stock 1,427 $29.34 $42K
Dec 2, 2025 SS Sean Saint - Officer Open-market sale Common Stock 3,278 $29.34 $96K
Dec 2, 2025 MM Mike Mensinger - Officer Open-market sale Common Stock 1,063 $29.34 $31K
Dec 1, 2025 AL Adam Lezack Open-market sale Common Stock 906 $29.35 $27K
Dec 1, 2025 AL Adam Lezack Open-market sale Common Stock 500 $29.91 $15K
Dec 1, 2025 MP Maria Palasis Open-market sale Common Stock 906 $29.33 $27K
Dec 1, 2025 MP Maria Palasis Open-market sale Common Stock 500 $29.96 $15K
Oct 31, 2025 MP Maria Palasis Open-market sale Common Stock 1,287 $26.86 $35K
Oct 31, 2025 MP Maria Palasis Open-market sale Common Stock 119 $27.45 $3K
Oct 31, 2025 AL Adam Lezack Open-market sale Common Stock 1,368 $26.85 $37K
Oct 31, 2025 AL Adam Lezack Open-market sale Common Stock 38 $27.70 $1K
Oct 3, 2025 SF Stephen Feider - Officer Option exercise Common Stock 4,982 $5.10 $25K
Oct 3, 2025 SF Stephen Feider - Officer Open-market sale Common Stock 3,828 $21.52 $82K
Oct 3, 2025 SF Stephen Feider - Officer Open-market sale Common Stock 1,154 $22.28 $26K
Oct 3, 2025 SF Stephen Feider - Officer Option exercise Employee Stock Option (right to buy) 4,982 $0.00 -
Oct 1, 2025 SF Stephen Feider - Officer Option exercise Common Stock 15,018 $5.10 $77K
Oct 1, 2025 SF Stephen Feider - Officer Open-market sale Common Stock 14,918 $20.76 $310K
Oct 1, 2025 SF Stephen Feider - Officer Open-market sale Common Stock 100 $21.08 $2K
Oct 1, 2025 SF Stephen Feider - Officer Option exercise Employee Stock Option (right to buy) 15,018 $0.00 -
Sep 8, 2025 SF Stephen Feider - Officer Option exercise Common Stock 9,900 $5.10 $50K
Sep 8, 2025 SF Stephen Feider - Officer Open-market sale Common Stock 9,900 $21.13 $209K
Sep 8, 2025 SF Stephen Feider - Officer Option exercise Employee Stock Option (right to buy) 9,900 $0.00 -
Sep 5, 2025 SF Stephen Feider - Officer Option exercise Common Stock 100 $5.10 $510
Sep 5, 2025 SF Stephen Feider - Officer Open-market sale Common Stock 100 $21.00 $2K
Sep 5, 2025 SF Stephen Feider - Officer Option exercise Employee Stock Option (right to buy) 100 $0.00 -
Sep 4, 2025 MH Mark Hopman - Officer Option exercise Common Stock 656 $5.10 $3K
Sep 4, 2025 MH Mark Hopman - Officer Option exercise Common Stock 4,093 $5.10 $21K
Sep 4, 2025 MH Mark Hopman - Officer Open-market sale Common Stock 6,818 $19.97 $136K
Sep 5, 2025 MH Mark Hopman - Officer Option exercise Common Stock 11,411 $5.10 $58K
Sep 5, 2025 MH Mark Hopman - Officer Open-market sale Common Stock 11,411 $20.56 $235K
Sep 4, 2025 MH Mark Hopman - Officer Option exercise Employee Stock Option (right to buy) 656 $0.00 -
Sep 4, 2025 MH Mark Hopman - Officer Option exercise Employee Stock Option (right to buy) 4,093 $0.00 -
Sep 5, 2025 MH Mark Hopman - Officer Option exercise Employee Stock Option (right to buy) 11,411 $0.00 -
Sep 2, 2025 MM Mike Mensinger - Officer Open-market sale Common Stock 1,089 $18.86 $21K
Sep 2, 2025 SF Stephen Feider - Officer Open-market sale Common Stock 1,462 $18.86 $28K
Sep 2, 2025 SS Sean Saint - Officer Open-market sale Common Stock 3,359 $18.86 $63K
Sep 2, 2025 MH Mark Hopman - Officer Open-market sale Common Stock 848 $18.86 $16K
Aug 22, 2025 SF Stephen Feider - Officer Option exercise Common Stock 4,413 $5.10 $23K
Aug 22, 2025 SF Stephen Feider - Officer Open-market sale Common Stock 4,413 $17.01 $75K
Aug 22, 2025 SF Stephen Feider - Officer Option exercise Employee Stock Option (right to buy) 4,413 $0.00 -
Aug 19, 2025 SF Stephen Feider - Officer Option exercise Common Stock 5,587 $5.10 $28K
Aug 19, 2025 SF Stephen Feider - Officer Open-market sale Common Stock 5,587 $17.03 $95K
Aug 19, 2025 SF Stephen Feider - Officer Option exercise Employee Stock Option (right to buy) 5,587 $0.00 -
Aug 19, 2025 MH Mark Hopman - Officer Option exercise Common Stock 16,158 $5.10 $82K
Aug 19, 2025 MH Mark Hopman - Officer Open-market sale Common Stock 16,158 $16.61 $268K
Aug 19, 2025 MH Mark Hopman - Officer Option exercise Employee Stock Option (right to buy) 16,158 $0.00 -
BDP $PRCT
PROCEPT BioRobotics Corp
